What do antineutrophil cytoplasmic antibodies (ANCA) tell us?

被引:48
作者
Savige, J [1 ]
Pollock, W [1 ]
Trevisin, M [1 ]
机构
[1] Univ Melbourne, No Gen Hosp, Dept Med, Austin Hlth No Hlth, Epping, Vic 3076, Australia
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2005年 / 19卷 / 02期
关键词
small-vessel vasculitis; Wegener's granulomatosis; microscopic polyangiitis; antineutrophil cytoplasmic antibodies (ANCA); neutrophil-specific antibodies; direct ELISA; capture ELISA; indirect immunofluorescence; proteinase; 3; myeloperoxidase;
D O I
10.1016/j.berh.2004.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antineutrophil cytoplasmic antibodies (ANCA) are autoantibodies directed against antigens found in the cytoplasmic granules of neutrophils and monocytes. ANCA testing is usually performed to help diagnose or exclude Wegener's granulomatosis and microscopic polyangiitis. The three most commonly used assays are indirect immunofluorescence (IIF) and the direct and 'capture' enzyme-linked immunosorbent assays (ELISAs) for ANCA directed against proteinase 3 (PR3) and myeloperoxidase (MPO). Although the International Consensus Statement for Testing and Reporting ANCA recommends that all sera are screened for ANCA by IIF and that IIF-positivity is confirmed by direct ELISAs, some laboratories test by direct ELISA alone, others screen with direct ELISA and confirm positive sera by IIF, and a few use capture ELISAs. This chapter discusses the various forms of vasculitis associated with ANCA, the usefulness of each of the ANCA assays and how ANCA testing can be used in the management of patients with small-vessel vasculitis.
引用
收藏
页码:263 / 276
页数:14
相关论文
共 68 条
[31]   INACTIVATION OF PEROXIDASES OF RAT BONE-MARROW BY REPEATED ADMINISTRATION OF PROPYLTHIOURACIL IS ACCOMPANIED BY A CHANGE IN THE HEME STRUCTURE [J].
LEE, E ;
HIROUCHI, M ;
HOSOKAWA, M ;
SAYO, H ;
KOHNO, M ;
KARIYA, K .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (11) :2151-2153
[32]   ANTIBODY TO SACCHAROMYCES CEREVISIAE (BAKERS-YEAST) IN CROHNS-DISEASE [J].
MAIN, J ;
MCKENZIE, H ;
YEAMAN, GR ;
KERR, MA ;
ROBSON, D ;
PENNINGTON, CR ;
PARRATT, D .
BRITISH MEDICAL JOURNAL, 1988, 297 (6656) :1105-1106
[33]   Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis -: Can test-ordering guidelines improve diagnostic accuracy? [J].
Mandl, LA ;
Solomon, DH ;
Smith, EL ;
Lew, RA ;
Katz, JN ;
Shmerling, RH .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (13) :1509-1514
[34]  
NILES JL, 1989, BLOOD, V74, P1888
[35]   Specificity of cANCA for Wegener's granulomatosis [J].
Nolan, P ;
Singh, B .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1996, 26 (05) :720-721
[36]   Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate [J].
Pollock, W ;
Clarke, K ;
Gallagher, K ;
Hall, J ;
Luckhurst, E ;
McEvoy, R ;
Melny, J ;
Neil, J ;
Nikoloutsopoulos, A ;
Thompson, T ;
Trevisin, M ;
Savige, J .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (09) :680-683
[37]  
PUDIFIN DJ, 1994, CLIN EXP IMMUNOL, V97, P48, DOI 10.1111/j.1365-2249.1994.tb06578.x
[38]   Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease:: prevalence and diagnostic role [J].
Quinton, JF ;
Sendid, B ;
Reumaux, D ;
Duthilleul, P ;
Cortot, A ;
Grandbastien, B ;
Charrier, G ;
Targan, SR ;
Colombel, JF ;
Poulain, D .
GUT, 1998, 42 (06) :788-791
[39]   Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions [J].
Russell, KA ;
Wiegert, E ;
Schroeder, DR ;
Homburger, HA ;
Specks, U .
CLINICAL IMMUNOLOGY, 2002, 103 (02) :196-203
[40]  
SAVAGE COS, 1987, LANCET, V1, P1389